Cleared Traditional

K241113 - VIVIX-M (FDA 510(k) Clearance)

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241113 · Vieworks Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2025
Decision
269d
Days
Class 2
Risk

K241113 is an FDA 510(k) clearance for the VIVIX-M. Classified as Full Field Digital, System, X-ray, Mammographic (product code MUE), Class II - Special Controls.

Submitted by Vieworks Co., Ltd. (Anyang-Si, KR). The FDA issued a Cleared decision on January 16, 2025 after a review of 269 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1715 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vieworks Co., Ltd. devices

Submission Details

510(k) Number K241113 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 2024
Decision Date January 16, 2025
Days to Decision 269 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
162d slower than avg
Panel avg: 107d · This submission: 269d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUE Full Field Digital, System, X-ray, Mammographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1715
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

LK Consulting Group USA, Inc.
Priscilla Chung

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MUE Full Field Digital, System, X-ray, Mammographic

All 52
Devices cleared under the same product code (MUE) and FDA review panel - the closest regulatory comparables to K241113.
Senographe Pristina
K260087 · GE Medical Systems SCS · Mar 2026
HESTIA
K243420 · Genoray Co., Ltd. · Jul 2025
2430TCA with Xmaru W
K243849 · Rayence Co., Ltd. · Mar 2025
MAMMOMAT B.brilliant
K233539 · Siemens Medical Solutions USA, Inc. · Mar 2024
RMF-2000
K220073 · DRTECH Corporation · Jan 2023
Planmed Clarity 2D, Planmed Clarify S
K211720 · Planmed OY · Jul 2022